FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at the simultaneous control of coccidiosis and iron deficiency. The compound comprises triazinones of formulas (I) 
or (II) 
wherein R1 means CF3-SO2- or CF3-S-, R2 means CH3, each R4, R5 and R6 means Cl (chlorine) or pharmaceutically acceptable salts thereof, and iron compounds (3+) specified in a group consisting of: multinucleated complex iron (III) and polysaccharide compounds and ammonium-iron (III) citrate. What is also declared is using the above compounds for producing drug preparations.
EFFECT: using the declared group of inventions is effective for the simultaneous control of coccidiosis and iron deficiency; it is accompanied by no adverse phenomena; the compound ingredients have no negative effects on each other; and their biological activity preserves.
17 cl, 15 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COCCIDIOSIS TREATMENT WITH INTRAMUSCULAR COMPOSITIONS OF TRIAZINE | 2013 |
|
RU2826432C2 |
| COCCIDIOSIS TREATMENT WITH INTRAMUSCULAR TRIAZINE COMPOSITIONS | 2013 |
|
RU2717821C2 |
| NEW TREATMENTS WITH TRIAZINES | 2013 |
|
RU2696265C2 |
| TREATING OR PREVENTING ANAEMIA IN PREGNANT NON-HUMAN MAMMALS | 2015 |
|
RU2712211C2 |
| COMPLEX IRON COMPOUNDS FOR THERAPEUTIC USE | 2018 |
|
RU2812636C2 |
| PREPARATION FOR TREATING AND PREVENTING ALIMENTARY ANAEMIA IN YOUNG PIGS | 2013 |
|
RU2540506C2 |
| ANTIPARASTIC MEANS FOR PIGS EIMERIOSIS TREATMENT AND PREVENTION | 2016 |
|
RU2639133C1 |
| TRIAZINE FORMULATIONS WITH SECOND ACTIVE INGREDIENT AND SURFACTANT (-S) | 2013 |
|
RU2652136C2 |
| COMPOSITION, METHOD OF ENTERIC INFECTION TREATMENT, METHOD OF NONSPECIFIC STIMULATION OF IMMUNE SYSTEM, METHOD OF DELIVERY OF BIOLOGICALLY ACTIVE MATERIAL IN INTESTINE UPPER REGIONS | 1992 |
|
RU2113220C1 |
| TRANSDERMAL USE OF TRIAZINES FOR COCCIDIAL INFECTION CONTROL | 2007 |
|
RU2484825C9 |
